Selling a medical suite in Singapore: what to know before you list it

Researched and written 2026-09-29 05:24 SGT · 11 sources listed at the end · draft 1 · figures verified against the named sources on the date shown; where a source has since moved, the element carries a marker.

A medical suite is a strata-titled unit in a commercial development — zoned Commercial, held under the same Building Maintenance and Strata Management Act regime as an office or retail unit — that is approved, or capable of being approved, for outpatient clinic use. In practice the stock concentrates in a handful of clusters: the Novena health campus (Novena Medical Center, the Mount Elizabeth Novena Specialist Centre cluster), Paragon Medical Centre and Camden Medical Centre on Orchard Road, and Gleneagles Medical Centre off Napier Road, each built around a hospital that supplies referrals. This page is for the owner of one of these units — a doctor selling on retirement or practice consolidation, an investor who bought the unit to let to a clinic, or an executor selling one out of an estate — deciding what the sale actually involves.

The short answer

• Legally this is a commercial property sale, not a residential one — no ABSD ever applied, no SSD applies regardless of how long you have held it, and there is no citizenship-tiered stamp duty to time around.
• The property sale and the clinic's ability to keep operating are two separate transactions. Your buyer's incoming operator needs a fresh HCSA licence before they can legally treat a patient at the address — your existing licence does not transfer with the title.
• How much clinical floor area your building's other owners have already used against URA and MOH's shared quota can decide whether a given buyer can run a clinic in your unit at all.
• The traded market is thin. Guides describe medical suites as among the least frequently traded, most consistently in-demand strata assets in Singapore — good for the price you eventually get, worse for how fast you get it.
• CPF cannot fund any part of the purchase for your buyer, on either side of the ledger, which narrows who can bid without financing lined up.

The mechanics: from decision to cash

A medical suite resells the way any strata commercial unit does: agree a price (or run a tender, common for higher-value units), sign an Option to Purchase, the buyer exercises it, and the sale completes through a conveyancing lawyer, typically eight to twelve weeks later if a mortgage is involved. Bank valuers use the same Direct Comparison Method as elsewhere, pulling recent comparable transactions from the same cluster; with so few transactions a year in any one building, valuers sometimes have to reach across the wider cluster (Novena to Novena, not Novena to Paragon) rather than within the building itself, and a thin comparable set can push a valuation conservative relative to what a motivated clinician-buyer will actually pay.

What makes this product different from an office or shop sale sits underneath the conveyancing, not inside it: whether the unit can keep being used as a clinic is governed separately from who owns it. URA and MOH's 2014 circular caps the total medical-clinic floor area a commercial building may carry at the lower of 3,000 sqm or 20% of its approved commercial GFA, precisely so a building does not quietly turn into a medical centre in all but name. If your building's clinic quota is already near that ceiling because of what other owners did years before you bought, a buyer who wants to open a new clinic in your unit may need MOH and URA's sign-off in a building that has none to spare — a fact almost never priced into the psf you see quoted for the cluster.

Beyond that, the steps are the ordinary commercial-resale sequence: decide whether to engage an agent under an exclusive or non-exclusive Prescribed Estate Agency Agreement, market the unit (often quietly, given how few genuine buyers exist for a given cluster and price band), negotiate, and let the lawyers handle ACD exposure if the buyer is acquiring your unit through a share purchase of a property-holding entity rather than the unit directly — a structure more common here than in residential sales because many buyers already hold their practice premises through a company.

Eligibility: who can sell, and what stops you

Almost anyone can sell a medical suite — there is no citizenship or minimum-occupation-period bar the way HDB and some private residential products carry. The real constraints sit elsewhere. If a bank loan is outstanding, its terms (and any lock-in penalty) control your timing. If the unit is jointly owned by practice partners as tenants-in-common, every owner's consent is needed, and a partner who will not agree forces the same route as any co-owned property: negotiate a buyout or apply to the General Division of the High Court for an order for sale. If you lack the mental capacity to act, a donee under a Lasting Power of Attorney or a court-appointed deputy must act for you.

A second, product-specific constraint sits with the clinic rather than the unit. If you are the practising doctor and the licence is in your own name, closing or transferring the practice is a precondition to a clean sale of an owner-occupied suite — patient records, staff and any locum arrangements have to be wound down or handed to a successor practitioner on a timeline that has nothing to do with the property conveyancing clock. If you are an investor-landlord selling with a sitting clinic tenant, the tenancy itself (its remaining term, break clauses and whether the tenant's own licence is in good standing) is now the asset you are really pricing, more than the bricks.

Citizenship: SC, PR, foreigner and the FTA nationals

This is where selling a medical suite diverges hardest from every residential product on this site. A medical suite is non-residential property, so the Residential Property Act's approval regime, and the whole apparatus built around it — SLA approval for landed housing, the FTA carve-out for US, Swiss, Liechtenstein, Norwegian and Icelandic nationals treated as citizens for ABSD purposes — simply does not reach it. SLA's own foreign-ownership list requires approval only for residential property; a foreigner, a Singapore PR, a Singapore Citizen and a company incorporated anywhere can all buy or bid for a medical suite on the same footing. Your buyer pool is not narrowed by their passport. It is narrowed by whether they, or their tenant, can obtain an HCSA licence — a professional-registration question, not an immigration one.

That also means the entire ABSD ladder — 0% first property, rising through the PR and foreigner tiers, 65% for a trust — is simply absent from this transaction on the buy side, and there is no capital gains tax on either side regardless of who you are. A US citizen selling still carries the separate US tax system that follows citizenship anywhere in the world — worldwide income, the Foreign Earned Income Exclusion for services income (not investment gains), and up to US$250,000 (US$500,000 filing jointly) of gain excludable under Section 121 only if the property was your main home, which a medical suite structurally is not.

Taxes: BSD, ABSD, SSD, property tax and rental income

Additional Buyer's Stamp Duty does not apply to a medical suite under any buyer profile — ABSD is a duty on residential property, full stop, and this is not one. Seller's Stamp Duty does not apply either, on any holding period: SSD reaches residential property on its own schedule and industrial property on a separate one, but a fully commercial, non-industrial unit like a medical suite sits outside both. That removes the single biggest timing pressure that shapes when residential owners on this site are told to sell. Buyer's Stamp Duty still applies, on the non-residential schedule; I can confirm the top band (5% above S$1.5 million) with confidence, but the lower-band figures in what I read this run disagree between sources, so treat only the top-band rate as settled and get your lawyer's exact computation before relying on a number.

If you are GST-registered, or your turnover crosses the compulsory registration threshold, GST at 9% applies on top of the sale price, and separately on rent if you are letting the unit before selling it — the same rule that reaches an office or shophouse's commercial floor. A GST-registered buyer acquiring the suite for a GST-registered use can generally recover that input tax; an individual doctor-buyer who is not GST-registered cannot, which is a real difference in net cost between two buyers quoting the same headline price. Property tax follows the flat non-residential rate rather than the tiered owner-occupier and non-owner-occupier residential bands — there is no owner-occupier discount for practising in your own suite. [⚠ shophouse.gst.commercial_sale: sources differ; awaiting a ruling]

Rental income from a medical suite is taxed as ordinary income against actual, deductible expenses — mortgage interest, property tax, MCST fees, repairs — with no access to the 15% deemed-expense shortcut IRAS offers residential landlords, because that concession is written for tenanted residential property only. If you hold the suite through a company, rental income and any gain sit inside the corporate tax return at the prevailing corporate rate rather than your personal one, and an Additional Conveyance Duty exposure attaches if your buyer is instead acquiring shares in that company — up to 71% on the buyer's side where the target is a property-holding entity.

Borrowing: what your buyer's financing looks like

There is no MAS-mandated loan-to-value ceiling on commercial property the way there is on residential, and no Mortgage Servicing Ratio applies at all — MSR is an HDB and EC-specific rule that never reaches this product. In practice, market guides put commercial loans generally at 80-90% LTV, but strata commercial financing is reported to underwrite tighter in practice, around 60-70%, against MAS Notice 645's 80% ceiling. At least one bank markets a medical-suite-specific product at up to 90%, with a limited-period promotion advertised at up to 100% — that is one lender's own marketing claim, not a market rate, and I have not checked it against competing banks' medical-suite products this run.

TDSR applies to an individual buyer exactly as it would for any property loan; it does not apply to a company, which is one reason a practice buys through its own corporate entity as often as the doctor buys personally. CPF cannot fund any part of the purchase on either side — CPF Board's own housing-use framework does not list commercial property, medical suites included, so your buyer's downpayment and every instalment must be cash or bank-financed, with no CPF cushion the way a residential buyer has. There is no HDB financing option for this product at all, and because almost every medical suite trades as a completed resale unit rather than off a developer's progressive payment schedule, the floating-rate-during-construction question that shapes new-launch residential financing largely does not arise here.

Renovation, fit-out and change of use

A buyer taking over an already-approved clinic can often reuse most of the existing fit-out; a buyer converting a bare or non-medical commercial unit into a clinic is taking on a materially bigger project, and its cost sits well above an office refit. Guides put a straightforward GP or TCM clinic fit-out at roughly S$60,000-120,000, or about S$150-350 per square foot, rising to S$400-700 psf for a dental or imaging practice with heavier services and equipment; reported build timelines run six to eight weeks for GP or TCM, eight to twelve for dental, and ten to fourteen for an aesthetic or imaging clinic.

The approvals stack is longer than a normal commercial fit-out's because a clinic touches four separate authorities: BCA for structural, partition or M&E works, including any floor reinforcement for imaging or dental equipment; SCDF for a Fire Safety Certificate wherever the works touch compartment walls, exits, sprinklers or smoke detection, which a clinic layout usually does; BCA's accessibility standards for patient routes; and URA, if the unit was not already approved for clinic use, for a change-of-use lodgment that runs straight into the DC14-28 quota discussed above. A seller marketing an unapproved or under-quota unit as 'medical suite potential' is selling a probability, not a fact, until that quota check has actually been done.

Conveyancing: the property sale and the licence are two different transactions

This is the single most important operational fact on this page. Selling the unit and enabling the buyer to run a clinic in it are legally separate events that happen to be bundled in the same negotiation. The Healthcare Services Act licence a practising seller holds does not transfer with the title — MOH's own regulation page confirms Outpatient Medical Service is one of sixteen separately licensed categories, and secondary summaries of MOH's own guidance (its FAQ PDF did not render as readable text this run) state plainly that a fresh licence application is required, assessed on the incoming operator's own premises, governance and service standards. A buyer can complete the property purchase on schedule and still be unable to legally see a single patient at the address until that licence is granted — a gap this page cannot put a firm number of weeks on, because government sources did not give me one and the secondary guides did not either.

Sequencing that gap is the negotiation most residential conveyancing never has to have: does the buyer's own doctor apply for the new licence before or after completion, does the seller's practice keep operating (and billing) until the buyer is actually licensed, and does the sale-and-purchase agreement price in any downtime the buyer absorbs between completion and licensing. None of this is a government-set process; it is negotiated, unit by unit, usually by the lawyers on both sides once the commercial terms are agreed.

Ordinary strata due diligence still applies on top of all this: MCST accounts and AGM minutes for the last three years, sinking-fund adequacy, and any planned common-area works, because commercial MCST maintenance is not held to the residential BMSMA standard in practice and service-charge levels vary sharply by building age. If your building is one of the older clusters, expect a buyer's lawyer or agent to ask for this before, not after, the OTP is exercised.

Estate: when a medical suite is inherited

A medical suite passes through an estate the way any other property does — by survivorship if held in joint tenancy with a practice partner or spouse, or otherwise only after a Grant of Probate or Letters of Administration, since a licensed asset like this cannot be legally sold or transferred before the estate has authority to act. What does not pass automatically is the clinic's own licence: it sits with the individual practitioner or the corporate licensee, not with the unit, so heirs inheriting a doctor's practice premises inherit the real estate and, separately, face the same fresh-licence requirement any outside buyer would — unless a successor practitioner is already named and licensed in their own right, which is a succession decision worth making well before it becomes an estate one.

The voice: twelve questions about selling a medical suite

Every property page on this site answers the same twelve questions, in this order, in plain words, and two questions sort the reader before any of them. First: are you borrowing to buy or borrowing against it? Second: once you hold it, are you lending it out — in this case, letting it to a clinic operator rather than practising in it yourself? Cash and own use is close to pure appreciation with no carry. Cash and let out is a yield play, positive carry by construction, priced here on a 3.5-5.5% reported gross clinic-lease yield. Borrow and own use is negative carry by construction — interest with no rent offsetting it, true whether the occupier is a household or your own practice. Borrow and let out is the spread play, and for a medical suite the spread is unusually dependent on one tenant's licence staying in good standing.

C0: The play. Balance sheet or cash flow?

For an investor-landlord this is closer to a cash-flow play than most commercial real estate on this site: the asking price is built substantially on the clinic-lease income it produces, not just on land-banking appreciation, because the buyer pool of genuine clinic operators is thin enough that yield, not comparable psf, does most of the price-setting. For a practising owner-occupier it is a hybrid: a balance-sheet asset that also happens to be the roof over a real, ongoing operating decision — selling means relocating or winding down the practice, not just cashing out a holding.

C1: Balance sheet. What you own and what you owe

The balance-sheet mechanics are ordinary: an asset at market value, a loan against it, no CPF entanglement on either side since CPF never touched this purchase. What is not ordinary is that the clinic's licence has zero balance-sheet value and cannot be sold with the unit, while the practice's goodwill — its patient base, records and referral relationships — is a real, sometimes substantial asset that sits entirely outside the property transaction unless the parties separately negotiate a practice sale alongside it.

C2: Cash flow. What actually moves, and when

Buyer's Stamp Duty is due in cash within fourteen days of the agreement, on the non-residential schedule; GST, if you or your buyer are GST-registered, adds a further cash event on top of the price. No ABSD cash event exists on the buy side, and no SSD cash event exists on your side as seller, at any point in your holding period — two of the biggest cash-timing pressures on residential sellers on this site simply do not apply here. [⚠ shophouse.gst.commercial_sale: sources differ; awaiting a ruling]

C3: P&L. What it does to profit, which is not cash

A separate question from cash: your gain against your original purchase price, net of BSD paid then, agent commission and legal fees now, and any mortgage interest and MCST contributions paid while holding it. This gain is generally not taxable in Singapore unless the transaction pattern shows you were trading the property rather than holding it, the same rule that applies to every other property type on this site.

C4: Carry. Income minus financing cost

If you occupy and practise from the suite yourself while carrying a loan, carry is negative by construction — interest with no rent to offset it. If you let it to a clinic tenant, carry is rent minus interest, non-residential property tax and MCST fees, and here the product argues for a comparatively favourable carry: clinic leases reportedly run two to three years with renewal options, against shorter and more volatile office leases, which should mean fewer void months eating into the yield than an equivalent-priced office unit would see.

C5: Give and get. The trade, plainly

You give up the premises, any goodwill you choose to bundle with the sale, and — if you occupy it — the continuity of your own practice's address. You get cash, the removal of a mortgage, and the end of an MCST and property-tax obligation. What you no longer have to think about once the sale completes is your buyer's HCSA licensing timeline; that friction, real as it is, becomes their problem, not yours.

C6: Exposed to. What can move against you

Price, broadly tracking the general commercial-property cycle — office space prices rose 0.4% in Q2 2026 after a 0.2% rise in Q1, the closest proxy available since URA does not publish a separate index for medical suites. Specific to this product: whether your building's clinic-use quota under the 2014 circular has room left for a new operator, and whether a competing medical cluster near a newer hospital draws referral volume away from your building's captive base over the years you hold it.

C7: For how long. The horizon you are committing to

The sale itself runs the ordinary commercial-resale clock, roughly eight to twelve weeks from an accepted offer to completion where a mortgage is involved, but reaching an accepted offer at all is the real horizon question in a market this thin. Layered on top, if the transaction includes a change of occupier, is a licensing horizon this page cannot size for you — your buyer's clinic cannot legally open until MOH grants their own licence, and no government or secondary source I read this run gives a reliable lead time for that step.

C8: Failure cascade. If it goes wrong, in what order

Negative carry first — rent that does not cover interest and MCST, or an owner-occupier's interest bill with the practice winding down — hits cash flow; sustained cash-flow strain accumulates into a P&L loss; a loss deep enough turns into negative equity if the thin, illiquid medical-suite market forces a sale below the outstanding loan; negative equity becomes illiquidity, because a market this thin extends the time needed to find any buyer, let alone one at the right price; illiquidity ends in insolvency if the loan cannot be serviced from other means in the meantime. The thinness of this specific market is what makes the middle two steps slower and more dangerous here than in an office or retail equivalent.

C9: Liquidity. How fast this becomes money, and at what haircut

Slower than almost any other product on this site, and the haircut for a forced or quick sale is likely larger, not smaller, than for an equivalently priced office or retail unit. Guides describe medical suites as among the least frequently traded, most consistently in-demand strata assets in Singapore — low turnover cuts both ways: it protects price for a patient seller and punishes a seller who needs to move quickly, because the buyer pool at any given moment is narrow, split between operating clinicians and investors comfortable underwriting a single tenant's licensed income.

C10: Control. Can you move the outcome, or are you a price-taker?

Less than you might expect for an asset this specialised. You do not control how much of your building's clinic-use quota other owners have already consumed, and you do not control MOH's licensing timeline for your buyer. You do control your asking price, whether you sell with or without a sitting clinic tenant (which changes both the buyer pool and the yield story), any fit-out or A&A you complete before marketing, and whether you get the quota position checked and documented before you list, rather than leaving your buyer to discover it during due diligence.

C11: The exit. How you get out, and what getting out costs

The sale is the exit, and the costs are agent commission at the negotiated commercial rate, legal fees, Buyer's Stamp Duty already settled by your buyer, and GST if either party is registered — with no Seller's Stamp Duty to clear at any point and no capital gains tax on the way out. The one exit cost most residential pages do not carry is qualitative: if you are the practising doctor, your exit is also your practice's exit, and it needs its own separate close — records, staff, patient continuity — that the property conveyancing timetable does not track. [⚠ shophouse.commission.commercial_norm_2026: sources differ; awaiting a ruling]

So is now the moment?

It is closer to the moment if your building's clinic quota still has headroom (so your buyer pool includes anyone who wants to open a new practice, not only someone taking over an existing licence), if you are selling with a sound, well-documented sitting tenancy rather than a vacant unit a buyer has to license from scratch, and if you have already had the MCST accounts and sinking fund checked so nothing surfaces late in a buyer's due diligence. It is less the moment if your own licence and practice wind-down are not yet sequenced, because an owner-occupier selling mid-practice is negotiating two exits at once and usually gets a worse price on the property for it.

The broader market read is a proxy, not a direct answer: office space prices were up modestly through the first half of 2026 and office rents rose further in Q2, the closest general-commercial signal available, since URA does not track medical suites as their own category. Whether your specific cluster is trading thicker or thinner than that general commercial trend this quarter is not something I can verify from what I read this run.

The B2B spoke: a licence-readiness check for owners, agents and family offices

This is a draft of a service that does not yet exist as a signed offer, and nothing here is agreed. The gap this page keeps returning to — that a medical suite's title and its clinic's licence are two separate things, checked by two different authorities, on two different clocks — is answerable from public and semi-public sources before a single buyer walks through the door: how much of a building's DC14-28 clinic quota is already used, whether MOH's HCSA framework has any building-specific flags, and what a realistic licensing lead time looks like for the specific service category a buyer intends to run. Almost no one currently does this work before listing; it surfaces, expensively, during a buyer's own due diligence instead.

Three groups have a reason to want that check run in advance. First, the selling doctor or investor, who currently hears the quota-and-licensing story only from a marketing agent already paid to close the sale, not from a neutral read of URA's and MOH's own records. Second, a family office or private bank whose client holds one or more medical suites as part of a wider estate and needs to know, ahead of any sale conversation, whether the asset can even be re-let to a new clinic operator if the current tenant leaves. Third, the CEA-licensed agents who work this niche and would rather quote a buyer a real licensing timeline than an optimistic one.

Two rules constrain the design, the same two that constrain every spoke on this site. An agent may not collect commission from more than one party in the same transaction, and estate agency work without CEA registration carries a fine of up to S$75,000, imprisonment of up to three years, or both — so any such desk has to operate through a CEA-licensed agency, paid by one identifiable party, not by whichever side happens to be easiest to bill.

The realtor economics: what the agent earns, and where the incentive points

There is no fixed commission and no prescribed guideline for a commercial sale of this kind; the rate is negotiated and written into the Prescribed Estate Agency Agreement before any work begins, and market reporting puts commercial deals broadly in the same range as other private property, commonly around 2%. On a S$4.5 million medical suite — a plausible price at the psf levels reported for the Novena cluster — 2% is S$90,000, and market reporting on agent take-home puts the agent's own share of that, after their agency's split, meaningfully below the headline figure. [⚠ shophouse.commission.commercial_norm_2026: sources differ; awaiting a ruling]

The asymmetry that runs through every sale on this site runs harder here because the product is thin: an agent's genuine value in a market this narrow is finding the small number of real clinician-or-investor buyers who exist for your specific cluster and price band, work that takes real time and relationships. But the fee is paid on price at completion, exactly as it would be for a liquid condominium sale, so the commission structure does not distinguish between an agent who found you the one buyer in the market this year and one who happened to already have a list. [⚠ shophouse.commission.commercial_norm_2026: sources differ; awaiting a ruling]

The quota-and-licensing question bends the incentive a second way, and it can bend either direction. An agent paid to close your sale this quarter has no financial reason to tell a buyer their intended clinic use may hit the building's DC14-28 ceiling, or that licensing could take longer than the buyer assumes — that information can only slow the deal down or shrink the buyer pool the agent is trying to sell into. Naming this plainly is the only defence a reader has against it: ask your agent, in writing, whether the building's medical-use quota and your buyer's intended service category have actually been checked against MOH and URA's own records, not assumed from the fact that the building already houses other clinics.

What I could not verify

URA does not appear to publish a single page defining 'medical suite' as its own zoning class; this page's description of the product rests on the 2014 change-of-use circular (fetched and read this run) plus market and listing-portal commentary, not on a dedicated government definition. The non-residential BSD schedule's lower bands disagreed between the sources I read this run; only the top band above S$1.5 million is stated here with confidence. MOH's own HCSA FAQ document did not render as readable text on direct fetch this run, so the licence-transfer mechanics rest on a secondary guide's summary of it, cross-checked only against MOH's own regulation page confirming the 16-category framework in general terms. The psf and yield figures for the Novena cluster come from one commercial guide and listing-portal search summaries, not from a URA or JTC statistical series, because none exists for this asset class specifically. HL Bank's up-to-90%-or-100% LTV claim is that lender's own marketing, not verified against other banks' equivalent products this run.

Where to go next

Sources

• URA — Circular URA/PB/2014/28-DCG: New Guidelines on Change of Use of Commercial Spaces to Medical Clinics (joint with MOH Circular No 35/2014) (2014-12-23) · https://www.ura.gov.sg/Corporate/Guidelines/Circulars/dc14-28
• MOH — Healthcare services regulation and licensing (2026-09-29) · https://www.moh.gov.sg/others/health-regulation/healthcare-services-regulation-and-licensing/
• IRAS — Stamp duty, GST and property tax pages (reused from the existing fact ledger; not independently re-fetched this run) (2026-09-29) · https://www.iras.gov.sg/taxes/stamp-duty
• MAS — TDSR and commercial financing framework (reused from the existing fact ledger) (2026-09-29) · https://www.mas.gov.sg/
• CPF Board — Housing-use framework for CPF savings (reused from the existing fact ledger) (2025-11-03) · https://www.cpf.gov.sg/
• CEA — Estate agency scope, commission and licensing rules (reused from the existing fact ledger) (2026-05-13) · https://www.cea.gov.sg/
• ZeroABSD.com — Most Expensive Commercial & Industrial Property in Singapore by Type & Cluster (2026-09-01) · https://www.zeroabsd.com/guides/most-expensive-ci-property-singapore.html
• HL Bank — Medical Suite & Clinic Financing (2026-09-29) · https://www.hlbank.com.sg/en/business-banking/products/health-banking/medical-suite-and-clinic-financing.html
• FixMove.sg — Medical Clinic Renovation Singapore (2026-09-29) · https://www.fixmove.sg/medical-clinic-renovation-singapore.html
• Ohmyhome — Why Singapore condo sinking funds are under pressure in 2026 (2026-09-29) · https://pm.ohmyhome.com/why-singapore-condo-sinking-funds-are-under-pressure-in-2026-and-how-a-managing-agent-helps/
• Raffles Corporate Services — Healthcare Services Act (HCSA) Singapore 2026: A Licensing Guide for Clinics and Health Providers (2026-09-29) · https://rafflescorporateservices.com/healthcare-services-act-hcsa-singapore-2026-licensing-guide-clinics-health-providers/